Healthcare · Medical Devices
$16.11
−$0.14−0.86%
Delayed · · marketstack
−$0.64−3.82%over 1M
Price ÷ trailing earnings
Revenue grew +129.08% in FY2025, +120.22% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
What DCTH has filed with the SEC. This is not Delcath SYSTEMS, Inc.’s own investor relations site: these filings are the primary source that site publishes from.
Also filed under Medical Devices, ranked by how closely they sit beside DCTH.
From Item 1A of its most recent 10-K, filed February 2026.
And 15 more.
FDA approval
we may exhaust our capital resources, and as a result may be unable to further commercialize our products in the United States and the European Union and any other jurisdictions where we may receive regulatory approval for our products or conduct future …7 more themes are on Measure
Free, no card, and it does not expire. See what the paid plans add
The assistant answers from what DCTH has actually filed: 17 annual reports filed with the SEC, 4 Form 4 filings from the last year and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from DCTH's filings and figures. One a day without an account; a free account has its own, and no card.
See how much of Delcath SYSTEMS, Inc. each of these investors holds, and every quarter they moved.
Ten seconds. No card. Nothing to cancel.
Be told the moment a DCTH insider trades
Put Delcath SYSTEMS, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Delcath SYSTEMS, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Delcath SYSTEMS, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.
Free, no card, and it does not expire.
18 more events are on Measure
Free, no card, and it does not expire. See what the paid plans add
Out of 246 passages in this year’s Item 1A.
New this year
102 more passages are on Bespoke
Free, no card, and it does not expire. See what the paid plans add